论文信息 - Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery. - 字舞流文

Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery.

M. Fallon | S. Fleetwood-Walker | M. Mackean | L. Colvin | D. Storey | R. Mitchell

[1] M. Fallon,et al. From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2] H. Anderson,et al. Analgesia Mediated by the TRPM8 Cold Receptor in Chronic Neuropathic Pain , 2006, Current Biology.